"Death is my Heir"--Ferroptosis Connects Cancer Pharmacogenomics and Ischemia-Reperfusion Injury
- PMID: 26971867
- DOI: 10.1016/j.chembiol.2016.02.005
"Death is my Heir"--Ferroptosis Connects Cancer Pharmacogenomics and Ischemia-Reperfusion Injury
Abstract
Although they are key to precision medicine, pharmacokinetics and pharmacogenomics are currently plagued with inconsistent results. In this issue of Cell Chemical Biology, Shimada et al. (2016) use cell line selectivity and appropriate filters to improve the consistency and to identify biomarkers for the selectivity of lethal compounds. These insights may be useful for our understanding of how necrosis and ischemic injury are regulated.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Comment on
-
Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity.Cell Chem Biol. 2016 Feb 18;23(2):225-235. doi: 10.1016/j.chembiol.2015.11.016. Epub 2016 Feb 4. Cell Chem Biol. 2016. PMID: 26853626 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources